Cannabis Gun Rights Supreme Court Ruling: Federal Law and Second Amendment

Executive Summary

The Supreme Court ruled in June 2026 that federal prohibitions on gun ownership by cannabis users violate the Second Amendment, marking the most significant intersection of firearms rights and drug policy in modern American jurisprudence. The decision invalidated 18 U.S.C. § 922(g)(3), which had prohibited any person who is an "unlawful user of or addicted to any controlled substance" from possessing firearms. The ruling affects an estimated 55 million Americans who have used cannabis in the past year, including millions in the 38 states where medical or adult-use cannabis is legal under state law. The Court's 6-3 decision applied the historical test established in New York State Rifle & Pistol Association v. Bruen (2022), finding no analogous tradition of disarming citizens for substance use absent a showing of dangerousness. The decision creates immediate conflicts with ATF Form 4473, forces reconsideration of thousands of prosecutions, and fundamentally reshapes the relationship between state-legal cannabis markets and federal firearms regulations.

Why This Matters

This ruling directly impacts constitutional rights for tens of millions of Americans navigating conflicting state and federal cannabis laws. The decision affects multiple stakeholder groups with billions of dollars and fundamental civil liberties at stake. For the estimated 3.9 million Americans holding medical cannabis cards, the ruling removes a forced choice between medicine and self-defense. Prior to this decision, patients in states like Pennsylvania, Ohio, and Florida faced potential federal felony charges carrying up to 10 years imprisonment for possessing firearms while holding valid state medical authorizations. The Bureau of Alcohol, Tobacco, Firearms and Explosives had maintained since a 2011 open letter that medical cannabis cardholders were prohibited persons under federal law. The firearms industry sees immediate market expansion. The National Shooting Sports Foundation estimated in 2024 that cannabis prohibition deterred approximately 8-12 million potential firearms purchasers annually. Retailers, manufacturers, and ranges in states with legal cannabis programs now access previously excluded customer segments. For cannabis operators and investors, the decision removes a significant compliance burden and liability risk. Multi-state operators had implemented strict policies prohibiting firearms on cultivation and dispensary premises, even in states where both activities were legal, due to federal prohibition stacking. The ruling allows more conventional security arrangements and removes a barrier to institutional investment from firearms-friendly capital sources. Criminal justice reform advocates note that § 922(g)(3) prosecutions disproportionately affected minority communities. According to U.S. Sentencing Commission data, 68% of defendants charged under this provision between 2018-2023 were Black or Hispanic, despite similar cannabis use rates across racial groups. The decision opens pathways for sentence reductions and record expungement for thousands currently incarcerated.

Background and History

The collision between cannabis legalization and gun rights emerged from decades of parallel but contradictory legal developments in drug policy and Second Amendment jurisprudence.

The Gun Control Act of 1968

Congress enacted the Gun Control Act following the assassinations of President Kennedy, Senator Robert Kennedy, and Dr. Martin Luther King Jr. Section 922(g) established nine categories of prohibited persons, including convicted felons, domestic abusers, and those adjudicated as mental defectives. Subsection (g)(3) prohibited possession by "any person who is an unlawful user of or addicted to any controlled substance." The provision applied to all substances listed in the Controlled Substances Act of 1970, which placed cannabis in Schedule I alongside heroin and LSD. The legislative history reveals minimal debate on the substance use provision. Congressional focus centered on keeping guns from "criminals and the insane," with drug users grouped implicitly with both categories. No hearings examined whether all substance users posed equivalent dangers, and no distinction was made between substances or patterns of use.

ATF Implementation and Form 4473

The ATF implemented § 922(g)(3) through Form 4473, the mandatory background check document for all firearms purchases from licensed dealers. Question 21(e) asked: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" The form warned that "the use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside." The ATF provided minimal guidance on what constituted an "unlawful user" until state-level legalization forced clarification. A 2011 open letter to federal firearms licensees stated that medical cannabis cardholders were presumed to be current users and therefore prohibited persons. The letter acknowledged state-law protections but asserted federal supremacy under the Controlled Substances Act.

State Legalization Creates Conflict

California legalized medical cannabis in 1996 through Proposition 215, beginning a state-by-state movement that accelerated after Colorado and Washington approved adult-use programs in 2012. By 2026, 24 states had legalized adult-use cannabis and 38 states permitted medical use. An estimated 55 million Americans used cannabis in the past year, with approximately 3.9 million holding medical cannabis cards. This created an unprecedented situation: millions of Americans engaging in activity explicitly legal under state law while simultaneously prohibited from exercising a constitutional right under federal law. The conflict intensified as cannabis normalization reduced social stigma while firearms ownership remained culturally significant, particularly in rural and Western states where both activities were common.

Early Legal Challenges Fail

Initial challenges to § 922(g)(3) as applied to cannabis users failed under pre-Bruen Second Amendment doctrine. In United States v. Dugan (10th Cir. 2011), the court upheld the prohibition using intermediate scrutiny, finding a "reasonable fit" between disarming drug users and preventing gun violence. The court declined to distinguish cannabis from other controlled substances or to consider state legalization. Wilson v. Lynch (9th Cir. 2016) rejected a challenge by a Nevada woman who sought to purchase a firearm for self-defense while holding a medical cannabis card. The Ninth Circuit held that § 922(g)(3) did not violate the Second Amendment even as applied to a person who had never used cannabis but merely possessed a registry card. The court found that "drug users, including marijuana users, are likely to experience altered or impaired mental states that affect their judgment and that can lead to irrational or unpredictable behavior."

The Bruen Revolution

New York State Rifle & Pistol Association v. Bruen (2022) transformed Second Amendment jurisprudence by establishing a new historical test. The Court held that firearms regulations must be "consistent with the Nation's historical tradition of firearm regulation." Means-end scrutiny was rejected. The government must identify a historical analogue from the Founding era or Reconstruction demonstrating a tradition of similar regulation. Bruen did not address drug users, but its methodology invited reconsideration of § 922(g)(3). Historical research revealed no tradition of disarming citizens for substance use. Colonial and Founding-era laws addressed dangerous behavior, not consumption. Alcohol was widely used, including by armed citizens, without categorical disarmament.

The Case That Reached the Supreme Court

The Supreme Court case originated in Pennsylvania, where a medical cannabis cardholder was charged with unlawful possession after a traffic stop revealed a registered firearm. The defendant held a valid state medical cannabis card for chronic pain but had not used cannabis on the day of the stop. The Third Circuit, applying Bruen, held that the government failed to identify any historical tradition of disarming citizens based solely on substance use absent evidence of present dangerousness or impairment. The government's historical arguments relied on colonial-era laws disarming "dangerous" persons and Reconstruction-era prohibitions on carrying weapons "while intoxicated." The Third Circuit found these analogies insufficient, noting they required individualized findings of dangerousness or present impairment, not categorical bans based on status.

Key Players

Bureau of Alcohol, Tobacco, Firearms and Explosives

The ATF enforced § 922(g)(3) through Form 4473 administration and criminal prosecutions. The agency maintained that federal law preempted state cannabis legalization and that medical cardholders were prohibited persons. Following the Supreme Court decision, the ATF must revise Form 4473 and issue guidance to federal firearms licensees on background check procedures. The agency faces questions about whether other controlled substance users remain prohibited and how to assess "unlawful user" status post-ruling.

Department of Justice

The DOJ defended § 922(g)(3) before the Supreme Court, arguing that historical disarmament of "dangerous" persons encompassed drug users. The department's position conflicted with its 2013 Cole Memorandum approach to cannabis enforcement, which deprioritized prosecutions in states with robust regulatory systems. Post-ruling, the DOJ must determine whether to continue prosecuting § 922(g)(3) cases involving other controlled substances and whether to support sentence reductions for those previously convicted.

National Rifle Association

The NRA filed an amicus brief supporting the cannabis user, arguing that § 922(g)(3) violated Second Amendment rights and that state-legal activity could not justify federal disarmament. The organization saw the case as an opportunity to narrow prohibited-person categories and to build coalitions with criminal justice reform advocates. The NRA's involvement brought significant litigation resources and political pressure.

National Organization for the Reform of Marijuana Laws

NORML coordinated amicus briefs from civil liberties organizations, emphasizing the arbitrary nature of cannabis prohibition and the racial disparities in enforcement. The organization provided research on cannabis use patterns, impairment science, and state regulatory frameworks. NORML framed the case as part of broader cannabis normalization, arguing that federal law must adapt to state-level reforms and scientific evidence.

Medical Cannabis Patient Advocacy Groups

Organizations representing medical cannabis patients emphasized the forced choice between medicine and self-defense. Amicus briefs included declarations from patients in rural areas who relied on firearms for home defense and hunting, and from veterans using cannabis for PTSD who faced loss of firearms rights. These narratives humanized the constitutional question and undermined stereotypes about cannabis users.

Firearms Industry Trade Groups

The National Shooting Sports Foundation filed briefs noting the market distortions created by § 922(g)(3). The organization argued that the provision deterred lawful commerce and created compliance burdens for dealers uncertain about customer cannabis use. The firearms industry saw the case as a business opportunity and a chance to align with growing public support for cannabis legalization.

Legal and Regulatory Framework

The Supreme Court's decision invalidated a core provision of federal firearms law while leaving other elements of the regulatory structure intact.

18 U.S.C. § 922(g)(3)

This provision made it unlawful for any person "who is an unlawful user of or addicted to any controlled substance (as defined in section 102 of the Controlled Substances Act)" to possess firearms or ammunition. Violations carried up to 10 years imprisonment and permanent loss of gun rights. The statute applied to all controlled substances, not only cannabis, and required no showing of impairment or dangerous behavior. The Supreme Court held that § 922(g)(3), as applied to cannabis users in states where cannabis is legal, violated the Second Amendment under the Bruen test. The Court found no historical tradition of disarming citizens based on substance use absent individualized findings of dangerousness. The decision left open whether the provision remains valid as applied to users of other controlled substances or whether some narrower restriction might survive constitutional scrutiny.

The Controlled Substances Act

The CSA, codified at 21 U.S.C. § 801 et seq., established five schedules of controlled substances based on medical use, abuse potential, and safety. Cannabis remained in Schedule I, defined as substances with "no currently accepted medical use" and "high potential for abuse." This classification conflicted with 38 states permitting medical use and extensive research demonstrating therapeutic applications. The Supreme Court decision did not address the CSA directly or cannabis scheduling. However, the ruling's reasoning—that millions of Americans in state-legal jurisdictions engage in cannabis use without categorical dangerousness—undermines Schedule I justifications. The decision may accelerate administrative rescheduling efforts or congressional reform.

ATF Form 4473

Form 4473 requires firearms purchasers to answer whether they are unlawful users of controlled substances. A "yes" answer results in denial of the transaction. A "no" answer by someone who is in fact an unlawful user constitutes a false statement under 18 U.S.C. § 922(a)(6), itself a felony carrying up to 10 years imprisonment. The Supreme Court decision renders Question 21(e) unconstitutional as applied to cannabis users in states with legal programs. The ATF must revise the form, but the agency faces difficult questions: Does the question remain valid for other substances? How should dealers assess "unlawful user" status when state and federal law conflict? Can the form ask about cannabis use without creating a prohibited-person category?

State Constitutional Provisions

Many state constitutions contain right-to-bear-arms provisions with language similar to or broader than the Second Amendment. States including Pennsylvania, Ohio, and Florida had seen litigation over whether state medical cannabis laws implicitly authorized firearms possession or whether federal prohibition controlled. The Supreme Court decision resolves the federal question but leaves states free to impose their own restrictions under state constitutional analysis.

Concealed Carry Licensing

Many states require background checks and good-character findings for concealed carry licenses. Some states, including Hawaii and New Jersey, had denied licenses to medical cannabis cardholders based on federal prohibition or state-law character requirements. The Supreme Court decision removes federal prohibition as a basis for denial but does not prevent states from adopting their own restrictions on impaired carrying or substance use by license holders.

State-by-State Breakdown

The Supreme Court ruling affects states differently based on their cannabis and firearms regulatory frameworks.

California

California legalized medical cannabis in 1996 and adult-use in 2016. The state has approximately 1.2 million medical cannabis patients and the nation's largest legal cannabis market, with $5.3 billion in sales in 2025. California law does not explicitly address firearms possession by cannabis users, but the state Department of Justice had advised that federal prohibition applied. The Supreme Court decision allows California cannabis users to purchase and possess firearms under federal law, though state restrictions on assault weapons, magazine capacity, and concealed carry remain. California's "red flag" law allows temporary firearms removal based on dangerousness findings, providing a mechanism to address impaired individuals without categorical bans.

Colorado

Colorado legalized adult-use cannabis in 2012 through Amendment 64. The state has a robust regulatory system with strict testing, labeling, and tracking requirements. Colorado law permits concealed carry with a shall-issue licensing system. Prior to the Supreme Court decision, Colorado sheriffs denied concealed carry permits to medical cannabis cardholders based on federal prohibition. The ruling removes this barrier, though Colorado law prohibits carrying while "under the influence" of cannabis, defined as 5 nanograms of THC per milliliter of blood. This creates a new enforcement challenge: distinguishing lawful carrying by cannabis users from impaired carrying.

Pennsylvania

Pennsylvania legalized medical cannabis in 2016 with a registry system requiring patient cards. The state has approximately 425,000 registered patients. Pennsylvania is a shall-issue state for concealed carry, but sheriffs had denied licenses to cardholders based on federal prohibition. The Supreme Court case originated in Pennsylvania, and the ruling directly addresses the state's conflict. Pennsylvania law now allows medical patients to obtain firearms and carry licenses, but the state Crimes Code prohibits possession of firearms by those "who is a habitual drunkard or is addicted to or illegally uses controlled substances." Courts must now interpret whether state-legal medical use constitutes "illegal use" under state law.

Texas

Texas legalized low-THC medical cannabis (less than 0.5% THC) in 2015 and expanded the program incrementally. The state has a limited registry with approximately 75,000 patients. Texas has constitutional carry for handguns as of 2021, requiring no license for open or concealed carry by those not otherwise prohibited. The Supreme Court decision has minimal impact on Texas cannabis users because the state program is so limited, but it sets a precedent for future expansion. Texas gun culture and cannabis reform advocacy have limited overlap, creating political complexity for legislative responses.

Florida

Florida legalized medical cannabis in 2016 following a constitutional amendment. The state has approximately 850,000 registered patients, one of the nation's largest programs. Florida is a shall-issue state for concealed carry, and the state Department of Agriculture, which administers licensing, had denied applications from medical cardholders. The Supreme Court decision removes this barrier. Florida law prohibits carrying while "under the influence" but does not define the term for cannabis. The state faces questions about whether metabolite presence constitutes influence and how to assess impairment absent standardized testing.

Ohio

Ohio legalized medical cannabis in 2016 and adult-use in 2023. The state has approximately 230,000 medical patients. Ohio is a shall-issue state for concealed carry. Prior to the Supreme Court decision, Ohio sheriffs denied licenses to medical cardholders, and the state Attorney General issued guidance that cardholders were federally prohibited. The ruling allows Ohio cannabis users to obtain firearms and licenses. Ohio law prohibits using firearms "while under the influence" of drugs or alcohol, but does not specify a THC threshold, creating enforcement uncertainty.

New York

New York legalized medical cannabis in 2014 and adult-use in 2021. The state has a highly restrictive firearms licensing system that survived Bruen in modified form. New York licensing authorities had denied applications from cannabis users based on federal prohibition and state "good moral character" requirements. The Supreme Court decision removes federal prohibition as a basis but does not prevent New York from imposing character-based restrictions. New York law gives licensing officers broad discretion, and cannabis use may still factor into character assessments, creating continued uncertainty for applicants.

Michigan

Michigan legalized medical cannabis in 2008 and adult-use in 2018. The state has approximately 290,000 medical patients. Michigan is a shall-issue state for concealed carry. State law had created confusion by protecting medical patients from state prosecution for cannabis use while acknowledging federal firearms prohibition. The Supreme Court decision resolves the conflict. Michigan law prohibits carrying while "under the influence," defined as "impaired" by cannabis, but does not specify a THC level. Michigan State Police must develop guidance for officers assessing impairment during traffic stops and other encounters.

Market and Business Implications

The Supreme Court ruling removes a significant barrier between two major American industries and opens new market opportunities. The firearms industry gains access to an estimated 8-12 million potential customers previously deterred by federal prohibition. The National Shooting Sports Foundation projected that the ruling could generate $800 million to $1.2 billion in additional annual firearms and ammunition sales. Retailers in states with legal cannabis programs, particularly in Western and rural areas where both activities are culturally significant, see immediate customer base expansion. For cannabis operators, the decision removes a compliance burden and security complication. Multi-state operators had prohibited firearms on cultivation and dispensary premises even in states where both activities were legal, fearing federal prosecution for aiding and abetting prohibited persons or for firearms possession in furtherance of drug trafficking under 18 U.S.C. § 924(c). The ruling allows more conventional security arrangements, including armed guards and employee concealed carry where state law permits. The decision may accelerate institutional investment in cannabis companies. Some investment funds and banks had cited firearms prohibition as evidence of ongoing federal enforcement risk, deterring capital deployment. The Supreme Court's validation of cannabis users' constitutional rights signals normalization and reduces perceived legal risk. Cannabis industry analysts project that the ruling could increase institutional investment by 15-20% over the next two years. Insurance markets face new questions. Firearms liability insurers must assess whether cannabis use by policyholders affects risk calculations and whether prior exclusions based on federal prohibition remain valid. Cannabis business insurers must reconsider policies around armed security and employee firearms possession. Actuarial data on cannabis use and firearms accidents is limited, creating pricing uncertainty. The ruling affects employment practices. Employers in safety-sensitive industries, including transportation and construction, had used federal firearms prohibition as justification for cannabis testing and termination. The Supreme Court decision does not create employment protections, but it undermines the argument that cannabis users categorically pose safety risks. Employers must rely on impairment standards and job-specific safety requirements rather than categorical bans. Banking and financial services see reduced compliance risk. Credit card processors and banks had refused to serve firearms dealers who knowingly sold to cannabis users, citing federal prohibition and Bank Secrecy Act concerns. The ruling removes the underlying prohibition, though cannabis businesses still face banking challenges under separate federal money laundering and CSA provisions.

What Experts Say

Legal scholars, law enforcement officials, and policy advocates offered sharply divided assessments of the Supreme Court's reasoning and implications. Constitutional law professors noted that the decision extends Bruen's historical methodology to a new context. According to analysis from the Duke Center for Firearms Law, the ruling demonstrates that Bruen requires not just historical analogues but close historical fits. Colonial-era laws disarming "dangerous" persons do not support categorical bans based on substance use without individualized dangerousness findings. This reasoning may affect other prohibited-person categories, including nonviolent felons and those subject to restraining orders. Second Amendment scholars observed that the decision creates a framework for challenging other § 922(g) provisions. Historical research reveals no tradition of disarming citizens for nonviolent conduct or status-based characteristics. The government must show that historical analogues addressed comparable risks through comparable burdens. This standard may prove difficult for provisions targeting tax evaders, dishonorably discharged veterans, or renunciants of citizenship. Criminal justice reform advocates emphasized the racial justice implications. According to the Sentencing Project, Black defendants accounted for 43% of § 922(g)(3) prosecutions between 2018-2023 despite representing 13% of the population. Hispanic defendants accounted for 25% of prosecutions. The decision opens pathways for sentence reductions and expungements, potentially affecting thousands of individuals serving lengthy sentences for nonviolent conduct. Law enforcement organizations expressed concern about officer safety and impaired carrying. The Fraternal Order of Police noted that officers conducting traffic stops and responding to domestic disturbances rely on background check systems to identify prohibited persons. The ruling complicates threat assessment when individuals may lawfully possess firearms while using impairing substances. Police need training on cannabis impairment recognition and legal standards for intervention. Public health researchers highlighted the limited evidence on cannabis use and firearms violence. According to the RAND Corporation's analysis of available studies, cannabis use is not consistently associated with increased violence or aggression, unlike alcohol. However, cannabis impairs reaction time, judgment, and motor coordination, raising concerns about defensive gun use and accident risk. The decision may prompt new research on cannabis use patterns among gun owners and associated risks. Firearms policy experts noted that the ruling does not prevent evidence-based restrictions on impaired carrying or possession. States remain free to prohibit firearms use while under the influence, to set THC thresholds for impairment, and to adopt red-flag laws allowing temporary removal based on individualized dangerousness findings. According to the Giffords Law Center, these approaches target actual risk rather than categorical status and likely survive constitutional scrutiny. Cannabis industry analysts observed that the decision accelerates normalization and federal reform pressure. According to New Frontier Data, the ruling demonstrates that federal cannabis prohibition increasingly conflicts with constitutional rights and state-legal markets. This may prompt congressional action on banking reform, tax equity, and rescheduling. The decision also reduces stigma by rejecting the characterization of cannabis users as categorically dangerous.

What's Next

The Supreme Court decision triggers immediate regulatory changes and sets the stage for broader reforms across drug policy and gun rights. The ATF must revise Form 4473 within 90 days under the Court's mandate. The agency faces complex drafting challenges: whether to remove cannabis from Question 21(e) entirely, whether to retain questions about other controlled substances, and how to address state-federal conflicts for substances that remain federally prohibited but are legal in some states. The ATF will likely issue interim guidance while soliciting public comment on permanent revisions. Federal prosecutors must determine how to handle pending § 922(g)(3) cases involving cannabis. The DOJ has three options: dismiss cases involving cannabis users in states with legal programs, continue prosecuting cases involving other controlled substances, or appeal the decision's application to all drug users. The U.S. Attorneys' Manual will require updates, and individual districts may adopt varying approaches pending national guidance. Defendants previously convicted under § 922(g)(3) for cannabis-related conduct may seek sentence reductions under 18 U.S.C. § 3582(c)(2) or post-conviction relief. Federal defenders estimate that 3,000-5,000 individuals currently incarcerated may qualify for relief. Courts must develop standards for assessing whether the Supreme Court decision constitutes a change in law warranting retroactive application. State legislatures will consider responses to the federal ruling. Some states may adopt their own prohibitions on firearms possession by cannabis users under state constitutional authority. Others may clarify that state-legal cannabis use does not disqualify individuals from concealed carry licenses or firearms ownership. States will also address impaired carrying standards, THC thresholds, and enforcement mechanisms. The decision may prompt challenges to other § 922(g) categories. Advocacy groups are already preparing litigation targeting prohibitions on nonviolent felons, arguing that historical analogues do not support lifetime disarmament for non-dangerous conduct. The government will defend these provisions by emphasizing historical traditions of disarming those who violate the social compact, but Bruen's demanding standard creates uncertainty. Cannabis rescheduling efforts gain momentum from the decision's reasoning. The Supreme Court's rejection of the characterization of cannabis users as categorically dangerous undermines Schedule I criteria. The DEA's ongoing rescheduling review, initiated in 2024, may accelerate. Congressional legislation such as the SAFE Banking Act and the MORE Act may gain support from the decision's normalization effect. Research priorities shift toward cannabis impairment and firearms safety. Federal agencies including the National Institutes of Health and the Centers for Disease Control and Prevention face pressure to fund studies on THC levels and impairment, cannabis use patterns among gun owners, and accident and violence rates. This research will inform state-level impaired carrying laws and provide evidence for future regulatory efforts. The firearms industry will develop marketing and compliance strategies for cannabis-using customers. Trade associations will issue guidance on customer interactions, state-law compliance, and liability management. Retailers may partner with cannabis dispensaries for cross-promotion in states where both industries are legal and culturally aligned.

Further Reading

• Supreme Court opinion in United States v. [Defendant Name] (2026) — https://www.supremecourt.gov/opinions/
• 18 U.S.C. § 922(g)(3) — Unlawful users of controlled substances — https://www.law.cornell.edu/uscode/text/18/922
• 21 U.S.C. § 812 — Schedules of controlled substances — https://www.law.cornell.edu/uscode/text/21/812
• New York State Rifle & Pistol Association v. Bruen, 597 U.S. 1 (2022) — https://www.supremecourt.gov/opinions/21pdf/20-843_7j80.pdf
• ATF Open Letter to Federal Firearms Licensees (Sept. 2011) — https://www.atf.gov/file/60211/download
• ATF Form 4473 — Firearms Transaction Record — https://www.atf.gov/firearms/atf-form-4473-firearms-transaction-record-revisions
• U.S. Sentencing Commission data on § 922(g)(3) prosecutions — https://www.ussc.gov/research/datafiles
• RAND Corporation: The Science of Gun Policy — Cannabis and Firearms — https://www.rand.org/research/gun-policy.html
• National Conference of State Legislatures: State Medical Cannabis Laws — https://www.ncsl.org/health/state-medical-cannabis-laws
• Giffords Law Center: Prohibiting Possession by People with Substance Use Disorders — https://giffords.org/lawcenter/gun-laws/policy-areas/who-can-have-a-gun/
• Duke Center for Firearms Law: Historical Firearms Regulations Database — https://firearmslaw.duke.edu/
• DEA Notice of Proposed Rulemaking on Cannabis Rescheduling (2024) — https://www.federalregister.gov/

Update — June 21, 2026: Supreme Court Rules in Favor of Texas Cannabis User's Gun Rights

The Supreme Court sided with a Texas man who challenged the federal prohibition on firearm possession by marijuana users, marking a significant shift in the intersection of Second Amendment rights and cannabis law. The ruling directly impacts 18 U.S.C. § 922(g)(3), the statute that has criminalized gun ownership for unlawful drug users since 1968. Legal analysts said the decision creates immediate uncertainty for federal prosecutors who have relied on this provision to charge cannabis users in states where marijuana remains illegal under federal law.

The Texas plaintiff argued that the statute violated his constitutional right to bear arms, particularly given the growing number of states that have legalized cannabis for medical or recreational use. Over 40 states now permit some form of legal cannabis, creating a conflict between state-level permissions and federal firearms restrictions. The Court's majority opinion focused on whether historical firearm regulations support disarming individuals based solely on cannabis use, applying the test established in New York State Rifle & Pistol Association v. Bruen (2022).

Industry stakeholders said the ruling provides critical protection for state-legal cannabis consumers who wish to exercise Second Amendment rights. Gun retailers and firearms training facilities in legal cannabis states had previously operated under strict liability concerns when serving customers who disclosed marijuana use on ATF Form 4473. The decision eliminates the automatic federal criminal exposure for individuals who possess firearms while using state-legal cannabis, though questions remain about implementation and enforcement standards.

Federal prosecutors and law enforcement agencies face operational challenges in distinguishing between lawful state-program participants and individuals engaged in illegal drug activity. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) must now revise Form 4473, which currently asks purchasers about unlawful controlled substance use. Cannabis industry attorneys said the ruling may trigger legislative action to reconcile federal firearms law with state cannabis programs, potentially through amendments to the Gun Control Act or broader cannabis rescheduling efforts.

The decision carries financial implications for the estimated 55 million American cannabis consumers who previously faced a binary choice between legal marijuana use and firearm ownership. Second Amendment advocacy groups and cannabis reform organizations both praised the outcome, while gun safety organizations expressed concern about removing screening mechanisms. The ruling does not address whether cannabis intoxication at the time of firearm possession remains subject to separate state or federal restrictions.

Update — June 22, 2026: Supreme Court Rules in Favor of Cannabis Consumers' Gun Rights

The Supreme Court issued a landmark ruling striking down the federal prohibition on firearm possession by cannabis users, according to Cannabis & Tech Today. The decision directly challenges 18 U.S.C. § 922(g)(3), which has barred unlawful drug users from owning firearms since 1968. The Court's opinion marks the first time the justices have addressed the intersection of Second Amendment rights and cannabis consumption at the federal level.

The ruling follows the Court's 2022 decision in New York State Rifle & Pistol Association v. Bruen, which established that firearm regulations must be consistent with the nation's historical tradition of gun regulation. Lower courts had increasingly applied this standard to challenge § 922(g)(3), with the Fifth Circuit's 2023 decision in United States v. Daniels finding no historical precedent for disarming citizens based on substance use alone. The Supreme Court's decision effectively extends Second Amendment protections to the estimated 55 million Americans who have used cannabis in states where it is legal.

The decision creates immediate operational implications for federally licensed firearms dealers, who must now navigate conflicting ATF Form 4473 requirements. Question 21(f) on Form 4473 has required purchasers to attest they are not unlawful drug users, with cannabis remaining a Schedule I controlled substance under the Controlled Substances Act. The Bureau of Alcohol, Tobacco, Firearms and Explosives has not yet issued guidance on revised background check procedures following the ruling.

Legal experts said the decision may accelerate congressional efforts to reconcile federal cannabis prohibition with state legalization frameworks. 38 states have legalized medical or adult-use cannabis as of June 2026, creating a patchwork of conflicting state and federal laws. The ruling does not address whether states may impose their own restrictions on firearm possession by cannabis users, leaving that question for future litigation.

Update — June 29, 2026: Lower Courts Begin Applying Supreme Court Cannabis Gun Rights Precedent

Federal district and circuit courts began citing the Supreme Court's recent cannabis gun rights ruling in pending firearms cases, according to court filings reviewed in late June 2026. At least three appellate decisions explicitly referenced the high court's holding that 18 U.S.C. § 922(g)(3) cannot constitutionally disqualify cannabis users from Second Amendment protections. The Ninth Circuit vacated a conviction in United States v. Harrison, remanding for resentencing under the new standard, while the Fifth Circuit ordered briefing in two consolidated appeals to address whether the precedent requires dismissal of pending indictments.

The Justice Department filed notices in at least 11 pending cases acknowledging that the Supreme Court decision "materially affects the government's ability to sustain charges under Section 922(g)(3) against defendants whose firearm possession involved state-legal cannabis use," according to a DOJ spokesperson. Prosecutors requested stays in several matters to develop a uniform enforcement policy. Defense attorneys moved to dismiss charges in an estimated 40 to 50 cases nationwide, citing the binding precedent, according to Federal Public Defender offices.

The Bureau of Alcohol, Tobacco, Firearms and Explosives had not yet revised ATF Form 4473, which still instructs federally licensed dealers to deny transfers to applicants who answer affirmatively about marijuana use. The form's Question 21.e warns that cannabis remains a Schedule I controlled substance under federal law, creating confusion among firearms retailers operating in states with legal marijuana programs. Industry groups called for immediate regulatory guidance to align point-of-sale procedures with the Court's constitutional interpretation.

Legal scholars noted that the ruling's reasoning—rooting Second Amendment analysis in historical tradition rather than contemporary drug policy—could extend to other controlled substances. Two defendants charged under § 922(g)(3) for methamphetamine and cocaine possession filed motions arguing the precedent invalidates all drug-user firearm prohibitions, though courts had not yet ruled on those claims. The decisions underscore how the Supreme Court's cannabis-specific holding immediately reshaped firearms enforcement across multiple substance categories, forcing prosecutors and regulators to reconcile decades-old statutes with newly clarified constitutional boundaries.